Myocarditis after COVID-19 pneumonia: incidence and risk factors

Pol Arch Intern Med. 2023 Jun 23;133(6):16510. doi: 10.20452/pamw.16510. Epub 2023 May 25.

Authors

Magdalena M Martusewicz-Boros¹, Piotr W Boros², Dorota Piotrowska-Kownacka³, Marcin Paciorek⁴

Affiliations

¹ Third Department of Lung Diseases and Oncology, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland. m.martusewicz@gmail.com
² Department of Lung Pathophysiology, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland
³ First Department of Clinical Radiology, Medical University of Warsaw, Warsaw, Poland
⁴ Department of Adult Infectious Diseases, Medical University of Warsaw, Warsaw, Poland

PMID: 37227751
DOI: 10.20452/pamw.16510

No abstract available

MeSH terms

COVID-19* / complications
Humans
Incidence
Myocarditis* / epidemiology
Myocarditis* / etiology
Risk Factors
SARS-CoV-2